As viral pandemics and drug resistant bacteria become more common, it is imperative that the pharmaceutical industry increases its efforts to develop truly revolutionary treatments to combat infectious diseases. One area of focus is the development of new prophylactic and therapeutic vaccines. When a pandemic strikes, the traditional vaccine development and manufacturing process is cumbersome … Continue reading “Vaccine Innovations That Will Expedite Access for the Next Generation of Treatments”
Author: James Baker, Jr.
Dr. Baker is the inventor of the platform technology, founder of NanoBio and an internationally recognized expert in immunology and nanotechnology. Dr. Baker invented the NanoStat technology at the University of Michigan, where he is the Ruth Dow Doan Professor of Medicine and Head of Allergy and Immunology at the Medical School. As the Director of the University of Michigan Nanotechnology Institute, Dr. Baker leads a multidisciplinary team of 30 scientists focused on the use of nanotechnology in biomedical applications. He is one of three editors of the National Nanotechnology Initiative’s Research Directives, and a member of the Nanotechnology for Medicine and Biology study section at National Institutes of Health (“NIH”). Dr. Baker is a board-certified internist, allergist and immunologist, a member of American Board of Allergy and Immunology and a Fellow of the American College of Physicians. He is also a Fellow of the American Academy for the Advancement of Science.